Cardiovascular, metabolic, neurologic, mental-health, pelvic, and medication factors may be relevant.
A private, clinician-guided evaluation for concerns involving desire, arousal, erections, ejaculation, orgasm, discomfort, and hormonal health.
Sexual concerns may involve physical health, medications, hormones, mood, relationships, sleep, stress, pelvic factors, or several contributors at once.
Cardiovascular, metabolic, neurologic, mental-health, pelvic, and medication factors may be relevant.
Laboratory testing is selected from your history and symptoms; hormones are not assumed to be the cause.
Benefits, limitations, risks, cost, preferences, and follow-up are reviewed before treatment.
The appropriate approach depends on diagnosis, health history, contraindications, and personal goals.

Prescription medicines such as sildenafil or tadalafil may be considered for erectile dysfunction after contraindications and medication interactions are reviewed.
These medicines require sexual stimulation and must not be combined with nitrates.
Testosterone or menopausal hormone therapy may be discussed when symptoms, examination, laboratory findings, and established prescribing criteria support treatment.
Hormone therapy is not a universal treatment for erectile dysfunction or low desire.
Premature ejaculation may be addressed with behavioral strategies, topical therapies, counseling, or selected medications. Some SSRIs can delay ejaculation but can also reduce desire or impair orgasm.
The balance of possible benefit and sexual side effects should be reviewed individually.
Lubricants, moisturizers, prescription vaginal therapy, pelvic-floor care, counseling, or referral may be appropriate depending on symptoms and diagnosis.
Sexual pain, bleeding, or sudden changes should receive appropriate medical evaluation.
The FDA-approved injectable form may be considered for certain premenopausal women with acquired, generalized HSDD. It is not approved as a general treatment for erectile dysfunction or for men.
Specialty preparations may be discussed in limited circumstances after standard options, risks, administration requirements, and alternatives are reviewed.
Evidence for sexual-wellness use is limited. Compounded oxytocin, “Scream Cream,” Tri-Mix gel, and multi-ingredient dissolvable products are not FDA-approved for these marketed combinations.
Discuss concerns, timing, medications, health history, and goals confidentially.
Complete appropriate examination, testing, or referrals based on your presentation.
Review evidence, risks, limitations, cost, and alternatives together.
Reassess effectiveness, tolerability, safety, and changing needs.
Meet with an Alpha Hormones® medical provider to discuss your concerns and determine which evaluation and treatment options may be appropriate.